Email

Hepatitis C

Approximately 3.2 million Americans are infected with the hepatitis C virus. The virus, which is primarily transmitted through contact with infected blood, attacks the liver and causes cirrhosis and/or liver cancer when left untreated. There is currently no vaccine for hepatitis C.

Unfortunately, many people have no symptoms from infection and don't know they are infected until they develop signs of advanced liver disease. Because hepatitis C becomes chronic in more than 80 percent of cases, it is important to seek treatment from specialists who understand the condition and can work with you and your loved ones to establish the most appropriate treatment plan.

At the Jefferson Hepatitis C Center in Philadelphia, our expert hepatologists, pathologists, radiologists and other specialists will provide a coordinated approach to the management of your hepatitis C or coinfection of hepatitis C with hepatitis B and/or HIV.

Live Donor Liver Transplant Center

If damage to your liver cannot be controlled, a liver transplant may be necessary. Jefferson is home to the longest continuously active liver transplantation program in the Philadelphia area. In fact, we performed the first liver transplant in the Delaware Valley.

Jefferson is also designated a Live Donor Liver Transplant Center by the United Network for Organ Sharing (UNOS), the organization that administers the nation's policies on organ transplantation and procurement. The designation makes Jefferson a liver transplant program for both live donor and deceased donor livers.

Transplantation specialists at Jefferson have developed innovative therapies to improve the quality of life for our liver transplant patients, including new antirejection protocols. Our surgeons also use an innovative bloodless technique for removing the liver, eliminating the need for a blood transfusion and helping to improve the survival rate and reduce the length of hospital stays and infection.